MCM
ANIX icon

MAI Capital Management’s Anixa Biosciences ANIX Stock Holding History

MAI Capital Management’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed -$7.74K – 2219
2026
Q1 		$7.74K Buy
3,000
+300
+11% +$888 ﹤0.01% 3291
2025
Q4 		$8.42K Hold
2,700
– – ﹤0.01% 2918
2025
Q3 		$8.91K Hold
2,700
– – ﹤0.01% 2789
2025
Q2 		$8.91K Sell
2,700
-70
-3% -$200 ﹤0.01% 2792
2025
Q1 		$7.92K Sell
2,770
-150
-5% -$429 ﹤0.01% 2577
2024
Q4 		$6.78K Buy
+2,920
New +$9.07K ﹤0.01% 2664

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

MAI Capital Management's ANIX Position: Q2 2026 in Review

MAI Capital Management sold out of Anixa Biosciences (ANIX) in Q2 2026, closing a stake of 3,000 shares — an estimated $7.74K sold.

MAI Capital Management first reported a position in ANIX in Q4 2024 and held it in 6 quarters. The position peaked at $8.91K in Q3 2025. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • MAI Capital Management reported no remaining Anixa Biosciences position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 3,000 Anixa Biosciences shares in Q2 2026, an estimated $7.74K.
  • MAI Capital Management first reported a position in Anixa Biosciences in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Anixa Biosciences position peaked at $8.91K in Q3 2025.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.